deltatrials
Recruiting PHASE3 INTERVENTIONAL 2-arm NCT05974462

MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction) (MYTHS-MR)

Single-blind, Investigator-initiated, Randomized, Controlled Trial to Assess the Safety and Efficacy of Intravenous Corticosteroid Therapy to Treat Patients With Acute Myocarditis With Mildly Reduced Left Ventricular Ejection Fraction

Sponsor: Niguarda Hospital

Updated 8 times since 2023 Last updated: Apr 14, 2025 Started: May 24, 2024 Primary completion: Oct 1, 2026 Completion: Oct 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Acute Myocarditis, this trial is actively recruiting participants. The trial is conducted by Niguarda Hospital and has accumulated 8 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Dec 2023 · 2 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotRecruiting~May 2025 – ~Sep 2025 · 4 months · monthly snapshotRecruiting~Sep 2025 – present · 12 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting PHASE3

  2. May 2025 — Sep 2025 [monthly]

    Recruiting PHASE3

  3. Sep 2024 — May 2025 [monthly]

    Recruiting PHASE3

  4. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  5. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

Show 3 earlier versions
  1. Dec 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE3

  2. Oct 2023 — Dec 2023 [monthly]

    Not Yet Recruiting PHASE3

  3. Sep 2023 — Oct 2023 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Niguarda Hospital
  • University Hospital, Antwerp
Data source: University Hospital, Antwerp

For direct contact, visit the study record on ClinicalTrials.gov .